Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug approval
Pharma
Biogen and Reata build their blockbuster case for Skyclarys
With Skyclarys’ latest approval, the drug becomes the first cleared to treat the rare disease Friedreich's ataxia in Europe.
Fraiser Kansteiner
Feb 12, 2024 5:05pm
TG locks up international marketing partner for MS drug Briumvi
Aug 1, 2023 9:15am
Teva's flagship drug Austedo scores new approval at the FDA
Feb 21, 2023 4:28pm
Off-the-shelf T-cell therapy wins world-first approval
Dec 19, 2022 3:22pm
Bayer's Nubeqa debuts in new use across the pond
Nov 28, 2022 10:34am
Add Sobi's Kineret to the FDA's list of COVID treatments
Nov 9, 2022 5:25pm